Snapshot Highlights

• Pioneered South Asia and India’s first particle beam therapy program.
• Recipient of prestigious fellowships from the American Society of Oncology and European Society of Medical Oncology.
• Clinical Director of an advanced radiotherapy school, training numerous oncologists and physicists.
• Authored multiple international scientific publications in high-impact journals.
• Co-founder and Chairman of Optimus Oncology, dedicated to accessible rural cancer care.

Professional Experience & Leadership

Dr. Srinivas Chilukuri is a distinguished Radiation Oncologist recognized globally as a key opinion leader in high-precision radiation therapy, particularly particle beam therapy. His pioneering spirit led the establishment of the first clinical program in South Asia and India for particle beam therapy, offering advanced treatment modalities for pediatric cancers, prostate cancers, thoracic cancers, and sarcomas. Dr. Chilukuri also spearheaded the Advanced Radiotherapy School as its Clinical Director, a vital institution that has educated a significant number of oncologists and medical physicists in the intricacies of high-precision radiation techniques, thereby elevating the standard of cancer care delivery.

Expertise and Specializations

Dr. Chilukuri possesses a specialized focus on treating complex oncological conditions, with a deep expertise in pediatric cancers, thoracic cancers, lymphomas, genito-urinary cancers, and bone and soft tissue tumors. His commitment to advancing cancer treatment methodologies is evident in his extensive experience with cutting-edge technologies like particle beam therapy. He is dedicated to leveraging technological innovations to ensure equitable access to modern cancer care, particularly for underserved rural populations in India, and is instrumental in building sustainable healthcare models that can be replicated across various geographical regions.

Academic Achievements and Recognition

Dr. Chilukuri’s exceptional career is marked by rigorous training at world-renowned institutions and significant global exposure. His contributions to the field of oncology have earned him prestigious fellowships from the American Society of Oncology and the European Society of Medical Oncology, acknowledging him as one of the most promising oncologists of his generation. Furthermore, his academic prowess is reflected in numerous national and international awards and a substantial portfolio of international scientific publications, many of which have appeared in high-impact medical journals, underscoring his influence and contributions to the advancement of radiation oncology.